Erik Atkisson - 09 Aug 2023 Form 4 Insider Report for Rain Oncology Inc.

Role
General Counsel and CCO
Signature
/s/ Avanish Vellanki, Attorney-in-fact for Erik Atkisson
Issuer symbol
N/A
Transactions as of
09 Aug 2023
Net transactions value
$0
Form type
4
Filing time
11 Aug 2023, 21:04:00 UTC
Previous filing
03 Mar 2023
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +60,251 $0.000000 60,251 09 Aug 2023 Common Stock 60,251 $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 60,251 shares of the Issuer's common stock, one half of which will vest on May 9, 2024, with the remaining one half vesting in full on February 9, 2025, subject to the Reporting Person's continued service to the Issuer.